Literature DB >> 13389476

Inhibition of DOPA decarboxylase by aromatic acids associated with phenylpyruvic oligophrenia.

J H FELLMAN.   

Abstract

Entities:  

Keywords:  ADRENAL MEDULLA/metabolism; DESMOLASES; MENTAL DEFICIENCY/metabolism

Mesh：

Substances：

Year:  1956        PMID： 13389476     DOI： 10.3181/00379727-93-22773

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  A chemical investigation of the defects of myelination in phenylketonuria.

Authors:  L CROME; V TYMMS; L I WOOLF
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-05       Impact factor: 10.154

2.  The relationship between decreased 5-hydroxyindole metabolism and mental defect in phenylketonuria.

Authors:  C M PARE; M SANDLER; R S STACEY
Journal:  Arch Dis Child       Date:  1959-10       Impact factor: 3.791

3.  Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia.

Authors:  J H FELLMAN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-02       Impact factor: 10.154

4.  Abnormal amino acid metabolism and brain protein synthesis during neural development.

Authors:  J V Hughes; T C Johnson
Journal:  Neurochem Res       Date:  1978-08       Impact factor: 3.996

5.  Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia.

Authors:  V Praphanphoj; S A Boyadjiev; L J Waber; S W Brusilow; M T Geraghty
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

6.  [The influence of DOPA-transamination on DOPA-decarboxylation in vitro].

Authors:  K F Gey; F Messiha
Journal:  Experientia       Date:  1964-09-15

7.  Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics.

Authors:  D J Edwards; K Blau
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.